A Study of a Personalized Neoantigen Cancer Vaccine

NCT03639714 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Colorectal Cancer
Gastroesophageal Adenocarcinoma
Urothelial Carcinoma

Interventions

BIOLOGICAL: GRT-C901
BIOLOGICAL: GRT-R902
BIOLOGICAL: nivolumab
BIOLOGICAL: ipilimumab

Sponsor

Gritstone bio, Inc.

Collaborators

[object Object]